Pande Atul has filed 10 insider transactions across 1 company since April 2024.
Most recent transaction: a option exercise of 6000 shares of Immunovant, Inc. ($IMVT) on May 20, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | Immunovant, Inc. | $IMVT | Pande Atul | Director | M | Common Stock | 6000 | $8.43 | 142,731.0000 | 203,532,180 | 4.39% | 0.00% |
| May 20, 2026 | Immunovant, Inc. | $IMVT | Pande Atul | Director | M | Stock Option (right to buy) | 6000 | $0.00 | 270,252.0000 | 203,532,180 | 2.17% | 0.00% |
| May 20, 2026 | Immunovant, Inc. | $IMVT | Pande Atul | Director | S | Common Stock | 6000 | $32.00 | 136,731.0000 | 203,532,180 | 4.20% | 0.00% |
| April 7, 2026 | Immunovant, Inc. | $IMVT | Pande Atul | Director | A | Common Stock | 13880 | $0.00 | 136,731.0000 | 203,532,180 | 11.30% | 0.01% |
| April 7, 2026 | Immunovant, Inc. | $IMVT | Pande Atul | Director | A | Stock Option (right to buy) | 7061 | $0.00 | 7,061.0000 | 203,532,180 | 9999.99% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Pande Atul | Director | A | Common Stock | 16188 | $0.00 | 122,851.0000 | 0 | 15.18% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Pande Atul | Director | A | Stock Option (right to buy) | 7600 | $0.00 | 7,600.0000 | 0 | 9999.99% | 0.00% |
| Dec. 2, 2024 | Immunovant, Inc. | $IMVT | Pande Atul | Director | S | Common Stock | 7750 | $28.54 | 106,663.0000 | 0 | 6.77% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Pande Atul | Director | A | Common Stock | 11255 | $0.00 | 114,413.0000 | 0 | 10.91% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Pande Atul | Director | A | Stock Option (right to buy) | 4690 | $0.00 | 4,690.0000 | 0 | 9999.99% | 0.00% |